Evidence map›Paper›PMID 38179856›Full record

ArticleHealth policy and planning2024

National action plans on antimicrobial resistance in Latin America: an analysis via a governance framework.

Paula Avello, Lisa M Collins, Sonia A Gómez, Federico Luna, Mariano E Fernández Miyakawa, Helen M West, Graziella Iossa

Open access · goldAbstract read
In one paragraph

Article in Health policy and planning, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 2 countries.

Paula AvelloFaculty of Biological Sciences, School of Biology, University of Leeds, Woodhouse, Leeds LS2 9JT, UK.
Lisa M CollinsFaculty of Biological Sciences, School of Biology, University of Leeds, Woodhouse, Leeds LS2 9JT, UK.
Sonia A GómezServicio Antimicrobianos, INEI-ANLIS 'Dr. Carlos G. Malbrán', Buenos Aires CP1281, Argentina.
Federico LunaServicio Nacional de Sanidad y Calidad Agroalimentaria (SENASA), Buenos Aires CP1063, Argentina.
Mariano E Fernández MiyakawaInstituto Nacional de Tecnología Agropecuaria (INTA/CONICET), Buenos Aires CP1686, Argentina.
Helen M WestSchool of Biosciences, University of Nottingham, Sutton Bonington Campus, Loughborough LE12 5RD, UK.
Graziella IossaSchool of Life and Environmental Sciences, University of Lincoln, Lincoln LN6 7TS, UK.
University of Leeds · GBAdministración Nacional de Laboratorios e Institutos de Salud · ARLoughborough University · GBNational Agricultural Technology Institute · ARNational Food Safety and Quality Service · ARUniversity of Lincoln · GB

Funding

Biotechnology and Biological Sciences Research Council BB/T004681/1
6 · The paper itself

Abstract

In 2015, the World Health Assembly adopted a global action plan (GAP) on antimicrobial resistance (AMR). Member states were encouraged to develop their own national action plans (NAPs) in alignment with the GAP. To-date, in systematic assessments of NAPs, the Latin American specific context has not been previously analysed. Here we examined 11 Latin American NAPs published between 2015 and 2021 using content analysis. We focused on two approaches: (1) alignment between the strategic objectives and actions defined in the GAP, and those outlined in the NAPs via a content indicator; and (2) assessment of the NAPs via a governance framework covering 'policy design', 'implementation tools' and 'monitoring and evaluation' areas. We observed a high alignment with the strategic objectives of the GAP; however, the opposite was observed for the corresponding actions. Our results showed that the governance aspects contained within coordination and participation domains were addressed by every Latin American NAP, whereas monitoring and assessment areas, as well as incorporating the environment, would need more attention in subsequent NAPs. Given that AMR is a global health threat and collective efforts across regions are necessary to combat it, our findings can benefit member states by highlighting how to strengthen the AMR strategies in Latin America, while also supporting global policy formulation.

Indexed as

Anti-Bacterial AgentsDrug Resistance, BacterialGlobal HealthHealth PolicyHumansLatin AmericaAnti-Bacterial AgentsAntimicrobial resistanceglobal action plangovernancenational action plans

Identifiers

PMID38179856
PMCPMC10883663
OpenAlexW4390631766

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.